While European and United States guidelines for the management of Helicobacter pylori infection have been developed, there are no guidelines for the Asian Pacific.
International experts and recognised local authorities met in Singapore in 1997 to develop appropriate guidelines, taking into account the high background prevalence of infection, high incidence rates of gastric cancer and resource limitations.
Recommendations were made based on randomised controlled trials or where this was not possible, they were based on the current best available evidence or on good clinical practice.
A number of acceptable diagnostic tests for infection are available throughout the region.
The non-endoscopic methods of choice are the urea breath test or a locally validated antibody test.
If endoscopy was to be performed, a biopsy urease test was recommended as the test of first choice, with histology recommended only if this was negative.
Post treatment testing was not recommended for all patients ; a urea breath test was considered the test of choice if available.
All gastric and duodenal ulcer patients who are infected with H. pylori should be treated for H. pylori whether the ulcer is active or in remission. (...)
Mots-clés Pascal : Gastrite, Campylobactériose, Bactériose, Infection, Helicobacter pylori, Spirillaceae, Spirillales, Bactérie, Diagnostic, Indication, Traitement, Protocole thérapeutique, Dyspepsie, Carcinome, Estomac, Article synthèse, Homme, Asie, Appareil digestif pathologie, Estomac pathologie, Tumeur maligne
Mots-clés Pascal anglais : Gastritis, Campylobacter infection, Bacteriosis, Infection, Helicobacter pylori, Spirillaceae, Spirillales, Bacteria, Diagnosis, Indication, Treatment, Therapeutic protocol, Dyspepsia, Carcinoma, Stomach, Review, Human, Asia, Digestive diseases, Gastric disease, Malignant tumor
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0177528
Code Inist : 002B05B02F. Création : 11/09/1998.